Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? - Wikidata - wikimedia - TriplyDB

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?

http://www.wikidata.org/entity/Q35364152

about

Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.Nasal Carriage and Resistance Pattern of Multidrug Resistant Staphylococcus aureus Among Healthy Children in Kashan, Iran.Predictors of mortality in Staphylococcus aureus Bacteremia Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study Definitive Treatment for Methicillin-sensitive Staphylococcus aureus Bacteremia: Data versus a definitive answer?Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.Patient Variables Associated with Nafcillin Plasma Concentrations and Toxicity.β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.Comparative Effectiveness of Cefazolin versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin.Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome.Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin.Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series.Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.Outcomes of vancomycin plus a β-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.Safety of Anti-Staphylococcal Penicillins versus Cefazolin: A Systematic Review and Meta-Analysis.Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.Bioanalytical development and validation of liquid chromatographic-tandem mass spectrometric methods for the quantification of total and free cefazolin in human plasma and cord blood.Efficacy of cloxacillin versus cefazolin for methicillin-susceptible bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial

P2860

Q26779453-DC80B1F9-65E3-4E68-BDD3-8E592C65194C Q33947743-B2CE5C34-FADC-476D-AE79-B11E98FA2C50 Q34057545-27C04199-8CB8-495E-9DF1-172C03C890E6 Q34733572-5ACB3160-BCC9-48B0-B6FB-BC6AE0259C0E Q35940556-7FE919D2-F4FA-490C-937E-46383D92B09F Q35960730-E442A250-88CE-46A5-B2C9-EFEC3C7277EB Q36026942-BF294B6F-BD02-4701-8FDA-48A2F870CA1A Q36082891-41FDAB2E-E89B-4270-B127-F72C9510693E Q36087129-2EA980EC-F07B-44E4-9B19-20B23A74BC0F Q36096382-4C7529A5-44DB-4BDC-83CD-61513BA9D759 Q36171547-BEF7FDF3-63B6-4E32-8127-DB892E05EAE1 Q36206847-233ED980-064F-41E6-95C9-8B88A802F042 Q36335536-CE3F7769-A889-4328-A456-DA11050BF2A7 Q36836505-5EC66B4C-9D29-4D41-8FC5-E6F48A7C28FE Q37119971-95DB243E-EA9A-45D8-AC31-303DBBA3DBCD Q37203845-A6AD208B-AAED-4059-BC89-CB804C45CA06 Q37286901-74802BE7-676F-4984-AC2A-E4321BA71A73 Q37358755-AC29319D-A4DF-421E-8820-7B8D63876AE6 Q38132301-A39FC942-0E0B-4C20-98D2-2DCD0B453CF2 Q38797012-FAE27C22-5B57-48C9-B568-2572E4C9D866 Q38916860-718A772A-686D-482B-B6E2-26D8BD18CFBC Q39051288-A561B451-BADE-4197-91F1-DB26B3B7F866 Q39313894-7BB0897D-C1A4-4E1B-99B3-C269C8C57B4D Q40257163-AAFA7D0F-BF5D-4495-90F1-16A93EC64124 Q40305775-A24CA43A-3C25-4A3B-ADCE-10990178A669 Q40546633-AB04C30B-8460-4AB4-B9AC-A74D0666DEDA Q40655950-090A627E-00BD-4D1E-A2F2-BAA0657CEFE6 Q41526075-4FB3ED58-94DD-4BBF-B62C-69BB2642062F Q41742134-0BA77A98-ACC3-47BE-888A-4FCDD5C0A0AC Q41994740-E5A2B030-E45F-4313-9FA5-8BFE43E7597D Q42110143-F9476138-2971-4FA0-813F-40417A2571D8 Q42699621-C8219C39-3FE1-45B8-810C-9158EAA82091 Q44566052-FB8D01C8-65DD-4815-B63E-327F352FD03B Q46916150-D7D034DF-56ED-4BAF-BA96-7658D7399729 Q47634145-B481F415-031E-4F0E-8B49-A5B17E974466 Q50044360-B409C5BB-EAD5-44DC-AC60-39FE3D4F9519 Q52673578-B11ED60C-A981-4AED-84E0-A1CF7AA59281 Q53277668-77A684B5-D0F6-4D02-AB2F-A2ED24194206 Q54983489-A0276B0F-2016-4FC6-AC5A-0C55AA460322 Q58776515-F9270912-0142-4180-AB26-C1DE2630F894

P2860

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?

http://www.wikidata.org/entity/Q35364152

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@ast

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@en

type

label

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@ast

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@en

prefLabel

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@ast

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@en

P1433

Q35364152-9C47CA51-BC13-4CC9-B001-815DB1D9029F

P1476

Q35364152-36D6367B-D9B6-415B-8641-BA6639F201FF

P2093

Q35364152-5BE591B9-4D6A-448D-9815-72835AFDB17D

Q35364152-7A8D023F-CC9A-4235-9CA1-8CAF32DC5411

Q35364152-A4F4F838-4C8A-4F3A-B70C-2888881F3A4C

Q35364152-F92492E1-BB05-40C0-AF6E-65998CA7F3EF

P2860

Q35364152-0FAFF107-07FF-434F-87ED-81717AEED86F

Q35364152-18C1D721-0BDE-4FDE-A72D-11DD5DC04065

Q35364152-4286DCE1-9F49-4413-8B62-5ED1665FDE84

Q35364152-7632851D-4855-477C-8FB7-C0E2CD39C4A4

Q35364152-77108170-8969-43ED-ADF3-10BF1EB5CF4B

Q35364152-78A7B933-C3C7-409A-B4D8-953020C3906B

Q35364152-90F528BD-D851-4599-9C55-F5704BD52061

Q35364152-9CCAC732-9A9C-420E-8129-F527888338AE

Q35364152-C420CABD-4F9D-4AD4-8AE7-67DAA02AF0C7

Q35364152-EF72185A-C285-4E1E-BE62-9AFDA9C28325

P304

Q35364152-25ACCF07-4B78-48D8-84BB-FB16DB5A71E8

P31

Q35364152-F9DEDD21-7363-4C67-B80E-8FA2B4FA6350

P356

Q35364152-F2127F9F-7EDA-4332-9C7A-A3E921AC8A1A

P407

Q35364152-D23A3C31-01CC-4BD2-BE0C-5E9A8E89F448

P433

Q35364152-895E04D3-442E-4CF7-944A-BCFBEE0D42C7

P478

Q35364152-FDEF1D92-FA36-4467-BC58-E54A9230005B

P50

Q35364152-5DBC1209-8B7E-4C08-9A7B-7DB62583BB3C

Q35364152-B3112AB8-D0D3-4E25-BA59-383C9D648F0E

Q35364152-CF501F9F-E25B-4CD3-A887-01572559E57F

Q35364152-D18425B4-7118-4C4C-A127-E7AC46630E82

Q35364152-D8573BCB-4085-4877-902A-8F36CAD025A6

P577

Q35364152-5ED399D9-4CB2-47E1-9FAA-B6A702DE7AF6

P698

Q35364152-48856AB1-6E82-4038-9D38-45F7A88E032E

P932

Q35364152-9CEC858E-C9D6-4BF1-A9C7-2F393F6850B9

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Is cefazolin inferior to nafci ...... phylococcus aureus bacteremia?

@en

P2093

Eui-Chong Kim

http://www.w3.org/2001/XMLSchema#string

Nam Joong Kim

http://www.w3.org/2001/XMLSchema#string

Pyoeng Gyun Choe

http://www.w3.org/2001/XMLSchema#string

Sang-Won Park

http://www.w3.org/2001/XMLSchema#string

P2860

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.

Characterization of four beta-lactamases produced by Staphylococcus aureus.

Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.

Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.

Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.

Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.

Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.

Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis.

P304

5122-5126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00485-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21825299

http://www.w3.org/2001/XMLSchema#string

P932

3195033

http://www.w3.org/2001/XMLSchema#string